We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
On Friday, August 18, 2017, Aspen Pharmacare Canada officially completed the transfer of Canadian commercialization rights associated with five of AstraZeneca's anesthetic products.